MedTrace Logo

Circadian Rhythms of Aqueous Humor Dynamics in Humans

NCT00572936 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-10-24

Study results available
· View outcomes & findings →

Summary

This study is designed to identify physiological, pharmacological and pathological circadian fluctuations in aqueous humor inflow and outflow, systemic blood pressure and ocular blood flow in humans.

Conditions

Interventions

DRUG

Latanoprost

prostaglandin

DRUG

Dorzolamide

carbonic anhydrase inhibitor

DRUG

Timolol

beta blocker

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Carl B Camras, MD · University of Nebraska

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-13
Primary Completion
2009-11-01
Completion
2009-11-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00572936 on ClinicalTrials.gov